HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Determination of fucokinase activity in the blood of schizophrenic patients].

Abstract
An investigation was conducted into whether dopamine induces an alteration in the fucolysation of glycoproteins, starting from the dopamine hypothesis of schizophrenia and taking the fucokinase activity determined in erythrocytes of schizophrenic patients as parameter. As with patients with "schizoaffective psychosis" and those with manic-depressive disorders, who were likewise examined, it was found that the enzyme activity of schizophrenic patients was no different than that found in the blood of a control group.
AuthorsA Honza, R Jork, D Müller
JournalPsychiatrie, Neurologie, und medizinische Psychologie (Psychiatr Neurol Med Psychol (Leipz)) Vol. 41 Issue 9 Pg. 531-8 (Sep 1989) ISSN: 0033-2739 [Print] Germany
Vernacular TitleBestimmung der Fukokinaseaktivität im Blut schizophrener Patienten.
PMID2555828 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Phosphotransferases
  • Phosphotransferases (Alcohol Group Acceptor)
  • fucokinase
Topics
  • Adolescent
  • Adult
  • Aged
  • Erythrocytes (enzymology)
  • Humans
  • Middle Aged
  • Neurotic Disorders (enzymology)
  • Phosphotransferases (blood)
  • Phosphotransferases (Alcohol Group Acceptor)
  • Pilot Projects
  • Radiculopathy (enzymology)
  • Schizophrenia (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: